These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Homology modeling, molecular dynamics, and virtual screening of NorA efflux pump inhibitors of Bhaskar BV; Babu TM; Reddy NV; Rajendra W Drug Des Devel Ther; 2016; 10():3237-3252. PubMed ID: 27757014 [TBL] [Abstract][Full Text] [Related]
24. Understanding the Structure-Function Relationship of Lysozyme Resistance in Staphylococcus aureus by Peptidoglycan O-Acetylation Using Molecular Docking, Dynamics, and Lysis Assay. Pushkaran AC; Nataraj N; Nair N; Götz F; Biswas R; Mohan CG J Chem Inf Model; 2015 Apr; 55(4):760-70. PubMed ID: 25774564 [TBL] [Abstract][Full Text] [Related]
25. Structural basis for cooperative binding of azoles to CYP2E1 as interpreted through guided molecular dynamics simulations. Levy JW; Hartman JH; Perry MD; Miller GP J Mol Graph Model; 2015 Mar; 56():43-52. PubMed ID: 25544389 [TBL] [Abstract][Full Text] [Related]
27. Investigating the molecular mechanism of staphylococcal DNA gyrase inhibitors: A combined ligand-based and structure-based resources pipeline. Durdagi S; Tahir Ul Qamar M; Salmas RE; Tariq Q; Anwar F; Ashfaq UA J Mol Graph Model; 2018 Oct; 85():122-129. PubMed ID: 30176384 [TBL] [Abstract][Full Text] [Related]
28. Investigation of the functional contributions of invariant serine residues in yeast mevalonate diphosphate decarboxylase. Krepkiy DV; Miziorko HM Biochemistry; 2005 Feb; 44(7):2671-7. PubMed ID: 15709780 [TBL] [Abstract][Full Text] [Related]
29. Molecular docking studies to map the binding site of squalene synthase inhibitors on dehydrosqualene synthase of Staphylococcus aureus. Kahlon AK; Roy S; Sharma A J Biomol Struct Dyn; 2010 Oct; 28(2):201-10. PubMed ID: 20645653 [TBL] [Abstract][Full Text] [Related]
30. Improving the acidic stability of Staphylococcus aureus α-acetolactate decarboxylase in Bacillus subtilis by changing basic residues to acidic residues. Zhang X; Rao Z; Li J; Zhou J; Yang T; Xu M; Bao T; Zhao X Amino Acids; 2015 Apr; 47(4):707-17. PubMed ID: 25543264 [TBL] [Abstract][Full Text] [Related]
31. Molecular Docking, Molecular Dynamics Simulations, Computational Screening to Design Quorum Sensing Inhibitors Targeting LuxP of Vibrio harveyi and Its Biological Evaluation. Rajamanikandan S; Jeyakanthan J; Srinivasan P Appl Biochem Biotechnol; 2017 Jan; 181(1):192-218. PubMed ID: 27535409 [TBL] [Abstract][Full Text] [Related]
32. Insights into regioselective metabolism of mefenamic acid by cytochrome P450 BM3 mutants through crystallography, docking, molecular dynamics, and free energy calculations. Capoferri L; Leth R; ter Haar E; Mohanty AK; Grootenhuis PD; Vottero E; Commandeur JN; Vermeulen NP; Jørgensen FS; Olsen L; Geerke DP Proteins; 2016 Mar; 84(3):383-96. PubMed ID: 26757175 [TBL] [Abstract][Full Text] [Related]
33. Prediction of binding modes and affinities of 4-substituted-2,3,5,6-tetrafluorobenzenesulfonamide inhibitors to the carbonic anhydrase receptor by docking and ONIOM calculations. Samanta PN; Das KK J Mol Graph Model; 2016 Jan; 63():38-48. PubMed ID: 26619075 [TBL] [Abstract][Full Text] [Related]
34. Docking studies and molecular dynamics simulations of the binding characteristics of waldiomycin and its methyl ester analog to Staphylococcus aureus histidine kinase. Radwan A; Mahrous GM PLoS One; 2020; 15(6):e0234215. PubMed ID: 32502195 [TBL] [Abstract][Full Text] [Related]
35. Ligand-based pharmacophore modelling and screening of DNA minor groove binders targeting Staphylococcus aureus. Vijayalakshmi P; Selvaraj C; Shafreen RM; Singh SK; Pandian SK; Daisy P J Mol Recognit; 2014 Jul; 27(7):429-37. PubMed ID: 24895275 [TBL] [Abstract][Full Text] [Related]
36. In silico modeling of the type 2 IDI enzymes of Bacillus licheniformis, Pseudomonas stutzeri, Streptococcus pyogenes, and Staphylococcus aureus for virtual screening of potential inhibitors of this therapeutic target. Torktaz I; Shahbani Zahiri H; Akbari Noghabi K J Mol Graph Model; 2013 Feb; 39():176-82. PubMed ID: 23280415 [TBL] [Abstract][Full Text] [Related]
37. Screening of Potential Lead Molecule as Novel MurE Inhibitor: Virtual Screening, Molecular Dynamics and In Vitro Studies. Zaveri K; Kiranmayi P Curr Comput Aided Drug Des; 2017; 13(1):8-21. PubMed ID: 27748170 [TBL] [Abstract][Full Text] [Related]
38. Effective interaction studies for inhibition of DNA ligase protein from Staphylococcus aureus. Vijayalakshmi P; Daisy P J Recept Signal Transduct Res; 2015 Feb; 35(1):15-25. PubMed ID: 25055026 [TBL] [Abstract][Full Text] [Related]
39. Insight into the binding modes and inhibition mechanisms of adamantyl-based 1,3-disubstituted urea inhibitors in the active site of the human soluble epoxide hydrolase. Chen H; Zhang Y; Ye C; Feng TT; Han JG J Biomol Struct Dyn; 2014; 32(8):1231-47. PubMed ID: 23815795 [TBL] [Abstract][Full Text] [Related]
40. Sulfonylpiperidines as novel, antibacterial inhibitors of Gram-positive thymidylate kinase (TMK). Martínez-Botella G; Loch JT; Green OM; Kawatkar SP; Olivier NB; Boriack-Sjodin PA; Keating TA Bioorg Med Chem Lett; 2013 Jan; 23(1):169-73. PubMed ID: 23206863 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]